Santen Pharmaceutical (4536): Key takeaways from press seminar on ptosis-20260713
摩根大通·2026-07-13 22:12

J P M O R G A N Asia Pacific Equity Research 13 July 2026 Santen Pharmaceutical (4536) Key takeaways from press seminar on ptosis From 11:00 a.m. on July 13, Santen Pharmaceutical held a press seminar titled "The Realities and Challenges of Ptosis and the Current State of Treatment — New Options Brought by Eye Drops". Assistant Professor Mika Tanabe of the Department of Ophthalmology, Kyushu University Hospital, and Ms. Naoko Koezuka, the head of Santen's Global Commercial Strategy team, gave presentations. ...

Santen Pharmaceutical (4536): Key takeaways from press seminar on ptosis-20260713 - Reportify